These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429 [TBL] [Abstract][Full Text] [Related]
3. Cathelicidin-related antimicrobial peptide protects against ischaemia reperfusion-induced acute kidney injury in mice. Pan LL; Liang W; Ren Z; Li C; Chen Y; Niu W; Fang X; Liu Y; Zhang M; Diana J; Agerberth B; Sun J Br J Pharmacol; 2020 Jun; 177(12):2726-2742. PubMed ID: 31976546 [TBL] [Abstract][Full Text] [Related]
4. Cathelicidins Target HSP60 To Restrict CVB3 Transmission via Disrupting the Exosome and Reducing Cardiomyocyte Apoptosis. Yang Y; Huang C; Hui L; Song Y; Fu Y; Li M; Yang H; Wu J; Sun J; Xu W; Wei L J Virol; 2023 Mar; 97(3):e0143322. PubMed ID: 36916989 [TBL] [Abstract][Full Text] [Related]
5. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα. Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708 [TBL] [Abstract][Full Text] [Related]
6. The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure. Zhou Q; Pan LL; Xue R; Ni G; Duan Y; Bai Y; Shi C; Ren Z; Wu C; Li G; Agerberth B; Sluijter JP; Sun J; Xiao J Theranostics; 2020; 10(14):6167-6181. PubMed ID: 32483446 [No Abstract] [Full Text] [Related]
7. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury. Li Y; Chen B; Yang X; Zhang C; Jiao Y; Li P; Liu Y; Li Z; Qiao B; Bond Lau W; Ma XL; Du J Circulation; 2019 Aug; 140(9):751-764. PubMed ID: 31220942 [TBL] [Abstract][Full Text] [Related]
8. The Anti-Microbial Peptide LL-37/CRAMP Is Elevated in Patients with Liver Diseases and Acts as a Protective Factor during Mouse Liver Injury. Wertenbruch S; Drescher H; Grossarth V; Kroy D; Giebeler A; Erschfeld S; Heinrichs D; Soehnlein O; Trautwein C; Brandenburg LO; Streetz K Digestion; 2015; 91(4):307-17. PubMed ID: 25998843 [TBL] [Abstract][Full Text] [Related]
9. Cathelicidin Related Antimicrobial Peptide (CRAMP) Enhances Bone Marrow Cell Retention and Attenuates Cardiac Dysfunction in a Mouse Model of Myocardial Infarction. Klyachkin YM; Idris A; Rodell CB; Tripathi H; Ye S; Nagareddy P; Asfour A; Gao E; Annabathula R; Ratajczak M; Burdick JA; Abdel-Latif A Stem Cell Rev Rep; 2018 Oct; 14(5):702-714. PubMed ID: 29948752 [TBL] [Abstract][Full Text] [Related]
10. Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding. Yu J; Dai Y; Fu Y; Wang K; Yang Y; Li M; Xu W; Wei L Antiviral Res; 2021 Mar; 187():105021. PubMed ID: 33508330 [TBL] [Abstract][Full Text] [Related]
11. Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis. Zhao D; Feng P; Sun Y; Qin Z; Zhang Z; Tan Y; Gao E; Lau WB; Ma X; Yang J; Yu S; Xu X; Yi D; Yi W Cell Death Dis; 2018 Jun; 9(7):723. PubMed ID: 29925877 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia-reperfusion injury. Alakoski T; Ulvila J; Yrjölä R; Vainio L; Magga J; Szabo Z; Licht JD; Kerkelä R Basic Res Cardiol; 2019 Jan; 114(2):7. PubMed ID: 30635790 [TBL] [Abstract][Full Text] [Related]
13. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition. Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157 [No Abstract] [Full Text] [Related]
14. Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo. Hou M; Zhang N; Yang J; Meng X; Yang R; Li J; Sun T Cell Physiol Biochem; 2013; 32(3):614-23. PubMed ID: 24021961 [TBL] [Abstract][Full Text] [Related]
16. Cathelicidin Antimicrobial Peptide Levels in Atherosclerosis and Myocardial Infarction in Mice and Human. Höpfinger A; Schmid A; Karrasch T; Pankuweit S; Schäffler A; Grote K Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474156 [TBL] [Abstract][Full Text] [Related]
17. No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis. Kienhöfer D; Hahn J; Schubert I; Reinwald C; Ipseiz N; Lang SC; Borràs ÈB; Amann K; Sjöwall C; Barron AE; Hueber AJ; Agerberth B; Schett G; Hoffmann MH PLoS One; 2014; 9(12):e115474. PubMed ID: 25535966 [TBL] [Abstract][Full Text] [Related]
18. The Critical Role of the Antimicrobial Peptide LL-37/ CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis. Zhang M; Liang W; Gong W; Yoshimura T; Chen K; Wang JM Crit Rev Immunol; 2019; 39(2):83-92. PubMed ID: 31679249 [TBL] [Abstract][Full Text] [Related]